Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, tolerability, and pharmacokinetics study of MAM01 in an African population
PACTR202405686700781Phase 1Not yet recruiting
- Sponsor
- Gates Medical Research Institute
- Start
- Jan 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised trial in malaria comparing MAM01 with Placebo (2 arms). Planned start Jan 2025; status: not yet recruiting.
02
Drugs
MAM01
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202405686700781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202405686700781.